Russia's New Cancer Vaccine: Does It Work And Will It Benefit India? | India Today | Sneha Mord
A Russian-developed mRNA cancer vaccine, Enteromix, is drawing global attention after showing 100% efficacy in preclinical trials — particularly against aggressive forms like colorectal cancer. While the results are promising, it's important to note that these findings are limited to laboratory and animal models. Human trials are still pending.
If successful, Enteromix could signal a breakthrough in cancer treatment, shifting the field toward personalized, less toxic therapies. For countries like India, where cancer burden is high and access to cutting-edge care is uneven, the impact could be especially significant.
#indiatoday #snehamordani #health #cancer #cancertreatmentoptions #vaccine #mrnavaccine
Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you'll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!
India Today TV is India's leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.
Stay tuned for latest updates and in-depth analysis of news from India and around the world!
WhatsApp Channel: https://whatsapp.com/channel/0....029Va2AnW3JENxxg7OuJ
Download App: https://indiatoday.link/wHaj
Follow us: Official website: https://www.indiatoday.in/
Twitter: https://twitter.com/IndiaToday
Facebook: https://www.facebook.com/IndiaToday